Drug Research

Boehringer Ingelheim has introduced a new artificial intelligence (AI) and machine learning (ML) facility in London, strengthening its efforts to integrate advanced technologies into pharmaceutical research. The AI R&D centre will focus on applying AI models to support the...

A new integrated approach to long-read sequencing of archived tissue samples has been introduced through a collaboration between PacBio and Covaris, with the workflow set to be presented at the American Association for Cancer Research Annual Meeting. The jointly...

The U.S. Food and Drug Administration has released a draft guidance outlining safety assessment standards for human gene therapy products that incorporate genome editing technologies, marking a step toward streamlining development pathways for advanced therapies. Announced on April 14,...

Amazon Web Services has introduced Amazon Bio Discovery, an AI-powered application designed to streamline drug research by enabling scientists to design, test, and refine novel therapies with greater speed and precision. The platform leverages biological foundation models trained on...

Danish pharmaceutical major Novo Nordisk has entered into a strategic collaboration with OpenAI to embed artificial intelligence across its drug development operations, with the stated goal of accelerating the delivery of new treatments. Announced on Tuesday, the initiative is...

The molecule you choose to advance into development doesn't just define your science it defines your entire Chemistry, Manufacturing, and Controls roadmap. This article unpacks how early lead selection decisions ripple through CMC planning, regulatory timelines, and ultimately, your path to the clinic.

Strategic oversight and regulatory navigation in the pharmaceutical industry rely on an integrated approach to drug development consulting, ensuring that global clinical pipelines reach the market efficiently.